Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Todos announcement were in mid March. I think at the latest April 20th for updates. I also think the FDA will have a little more scrutiny on a Chinese product. That news release did mention they will be qualifying in a timely matter. Jorge Leon also mentioned certification could take a month. Mid to late April is my guess. If you use LinkedIn you can get an idea who some of the players are here from Todos Commissiong Emerald and Carie. Hope Todos can generate some sales from this distribution agreement.
Yeah Trump back padded here and that chick asking the question is hot. I am sure Trump thought the same thing she was in the front row. Todos maybe able to fill a gaps in covid testing but it ain't a home run.
Todos has infrared spectrometry detection which is pretty cool technology alot of folks in the space. They had it good flying under the radar looking to develop breast cancer tests in Romania. Then they make this guy there ceo. He sees an opportunity to exploit covid 19 testing (flavor of the month) with Todos at 2 cents and gets a good pop for the company. Cool but if they dont deliver in a month I see this going to a duce.
Emerald Organic and Carie Health care telemedicine company is how Todos gets it done. My guess is middle of April. By that time Abbott and the other big players will have taken care of the usa market. I had already looked at the two above names. I had to ask myself why in hell messing around with this turd? And then i remember it's a 8 cent stock. Googl ran 90 bucks yesterday I love when that gets volatile.Spy and Iwm are probably good shorts.
Option Schooling?Tastytrade for option trading. The guy who designed thinkorswim runs it. Its is based out of Chicago. Free online videos training and testing.
Yeah you too buddy. Stay safe gotta head 2nd shift R an D doesnt sleep.
Yeah no kidding it's a 8 cent sorry 7 cent stock.
Hit the ceo up on twitter.
Hearing more and more about the need for the blood test on cnbc. Todos not mentioned of course. You have to remember I think they have distribution agreement in Europe as well. Hopefully it will generate some income for this 8 center
Nope they don't. Not at this time. Better off buying googl or selling volatility in the option market the vix keeps dropping
EMOR partnership look it up. EMOR just received 5 million from bedrock capital.Not sure if that was designated for covid 19 testing. I have shares this is just a lottery ticket
Agree my man.
Jorge Leon is the only reason I am holding free shares dollar cost average 3 cents in this company. He is basically an advisor for a venture capital firm out of nyc. Do some dd and you can find it. Todos has exciting technology that maybe is better than diagnosing breast cancer than current protocol
Jorge Leon is the only reason I am holding free shares dollar cost average 3 cents in this company. He is basically an advisor for a venture capital firm out of nyc. Do some dd and you can find it. Todos has exciting technology that maybe is better than diagnosing breast cancer than current protocol
Yeah ceo scares me they are basically trying to be distributors of Chinese covid-19 tests. It us huge need. He talks on Twitter that they are trying to set up testing en masses. It's out there on twitter. So as investors we are hoping that the FDA will approve a Chinese test. But does this company from Israel with a few contacts in the states and no infrastructure in the United States think it's going to start testing people en masses? The one ace in the hole as I see it is Jorge Leon now he has street cred. This Gerold Commissiong cat not so much. Does his comments on twitter hint of failure? Maybe? Read them and read the comments on the AMBS board. Gotta remember it's a 8 cent stock.
I see you just opened a new account and spewing your crap all over the place. Interesting. The I Q of this board just dropped to a few points. I know you are bored in your moms basement and have no money for smokes. Just go back to watching porn and relax. Go Todos
Waiting for that FDA approval. Submitted 3/4/2020 by 3medical. Time will tell and will it move the needle ?
3Dmed website.
http://www.3dmedcare.com/
3D Med submitted to fda early March.
Submission: PEuA200026
Received 3/4/2020
Applicant 3d medicine Science and Technology
Device 3dmed 2019 nCoV qRT-PCE
Detection kit.
China clamps down on coronavirus test kit exports after accuracy questioned. This worries me too about Todos Medical getting approval from fda
Faulty Virus Tests Cloud China’s European Outreach Over Covid-19
By Andrea Dudik and Radoslav Tomek
March 31, 2020, 11:00 PM EDT
Updated on April 1, 2020, 3:04 AM EDT
Just google usa buying covid-19 from Chinese and see what comes up.
This worries me.
I have to admit I paid attention to this board and was excited about todos when it started moving. Actually was home in new york and stressed and drinking some good bourbon and might of pumped too much but was just stating info anybody could find. This board and contacts with reliable sources not associated with the company but can dig a little deeper than I can I decided to get my initial investment out. Free riding shares just incase they make a go of it. Again thanks for your advice
Not sure how I became a moderator of that board. I actually gained a lot of insight of what I was dealing with with the ceo track record off this board. I had no knowledge of anything you couldn't find off their web site twitter and facebook. and Jorge Leon is the real deal. I am not going keep posting about tomdf. They are real company with a pretty cool technology but I found out there is alot of competition in the space and based on who their ceo and his track record off this board. I sold my principal investment and the rest I can ride for free. They still have a chance to make a impact in diagnosis of breast cancer.
Dude I am just a normal guy that actually took your advice. I bought todos based on the beast cancer diagnosis you can look it up. And then the covid 19 hit and I was actually looked very promising but then the dilution and the CEO track record. The lack of appreciation in the stock. There is alot of competition in this space and to think these guys can get it done with a Chinese company?? Add that and now this deal with EMOD or what ever it's called. And I ain't no moderator of the board. Geez
I agree with you these test are qualified in china and Europe. In their release they mentioned it could take up to a month to qualify, will they be late to the party? Plus does usa want to do business with a Chinese company at this time even though there is a very big demand for these tests. I still hold shares but I lightened up I just dont like the way it acts with the dilution and all. I bought this for the breast cancer test anyway at 3 and 4 cents. I truely hope it's a home run
Dont like the action it's been fun. Will keep an eye out for it
Duly noted
I hear ya there. Time will tell
Chances they get FDA approval in the states??? Thoughts
I get your point there but I noticed that you have mentioned similar options about other stocks in the space. Thanks for warning everybody
Todos Medical is moving to the usa. Do some DD.
MM tend to do that EOD and it tends to be low volume.
Catty have a good friend that lives in Brooklyn who is currently in quarantine in his home in Shelter Island. He salesman in the city and 2 of his friends have this nasty virus. It's been 5 days with no symptoms so we are hoping he dodged a bullet.
Todos Medical does have a facebook page go over and give them a like. The CEO has Twitter page as well. Buying shares of this company is like a donation to their cause to fight covid-19 and breast cancer and hopefully make a little money in the process.
It all good catty. Again I bought into Todos based on the breast cancer story. Covid-19 story is a insurance that this company is the real deal.
Root for this guy he will make it happen.
Jorge Leon, PhD
Diagnostics
Jorge Leon is an internationally recognized expert and pioneer in the field of development and commercialization of clinical molecular diagnostics.
Dr. Leon has a PhD in Cellular and Molecular Biology from NYU and completed his post doctoral studies at the German Cancer Research Center in Heidelberg, Germany and Columbia University in NYC. Dr. Leon’s post doctoral and subsequent academic work at Columbia University in NYC focused on the early development of monoclonal antibody based tumor marker assays, circulating tumor cell detection and radio-immuno imaging devices, today in the market.
Dr. Leon transitioned into industry in 1990 and played an integral role in the founding and growth of the molecular diagnostics laboratories at Quest Diagnostics Incorporated. As director of molecular diagnostics, senior director of Biotechnology development and Vice president of Applied Genomics Dr. Leon spent twelve years helping build the menu and driving the molecular diagnostics strategy at Quest which is today the largest molecular diagnostics service laboratory in the world with over 1.2 billion in revenues.
In 2003, Dr. Leon founded Leomics Associates, Inc. a consulting firm that is engaged in an aggressive agenda to help catalyze the development of molecular diagnostics and personalized medicine (pharmacogenomics) in the US and globally. Leomics Associates specializes in identifying breakthrough opportunities and applying Dr. Leon’s proven ability to predict the trends and directions of the clinical esoteric diagnostics business. Dr. Leon and his experienced team specialize in helping start-up businesses, academic centers and established companies successfully build and commercialize innovative business strategies, product pipelines, test menus and technology platforms around molecular diagnostics and personalized medicine.
Leomics is very focused in two of the mega trends of diagnostics: Personalized Medicine (biomarkers for pharma and diagnostics) and Point of Care Diagnostics. Leomics has been very effective on helping customers build winning strategies, choosing the right product applications or technologies, and finding and structuring valuable merger and acquisitions deals.
Among Leomics Associates’ customers are some of the top specialized academic centers like Mayo Clinic, National Jewish Medical Center and City of Hope Medical Center. Besides helping novel successful genomics ventures like Solexa, Sequenom, Monogram Biosciences, Althea Diagnostics, Ikonisys, Orion Genomics, Risk Analysis Laboratories, Ativa Medical and Foundation Medicine among others, Leomics also works helping key large health care players like Medco, Abbott, Stratagene, Perkin Elmer, ABI, Boston Scientific, Inverness Medical, Ortho Diagnostics, Virtualscopics and many more, to identify, develop and commercialize the right diagnostic innovative product
In the last three years Dr. Leon has played a key role as a senior external consultant helping develop and implement the biomarker business strategies of the five leading personalized medicine efforts in the industry today: Medco Health Solutions, Debiopharm, Novartis, GE Health Care and Foundation Medicine (a spin off from Harvard’s Dana Farber Cancer Center and MIT’s Broad’s Institute).
Cool prosper my man.
Eating crow bro
I like you lukin4winners. I hope you do well no matter how it pans out. But if you believe in the story and invest in a little penny stock from Israel that made a difference in saving lives, well hell you should be rewarded. I say 3 or 4 bucks and this gets acquired by another diagnostics company. In my opinion of course. What hell do I know its 630 on the east coast and we got a virus changing everybody's life. Sure does suck